HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever To Create $10 Mil. Settlement Fund For Suave Hair-Smoother Ills

This article was originally published in The Rose Sheet

Executive Summary

Unilever settles class-action suits in three states related to alleged injuries from use of its Suave Professionals Keratin Infusion 30-Day Smoothing Kit, which plaintiffs claim was a powerful chemical relaxer rather than a non-toxic conditioning system as advertised. The firm will establish funds totaling more than $10 million to reimburse consumers for purchases and medical expenses.

You may also be interested in...



MoCRA-Required Recordkeeping, Reporting Now ‘Fair Game’ For Litigants – Crowell & Moring

Cosmetic product manufacturers can expect the plaintiffs’ bar to leverage new record-keeping, GMP and other provisions of the Modernization of Cosmetic Regulations Act to bring or advance litigation, Crowell & Moring attorneys say. They note some defensive tactics that could prove effective.

US Proposed Class Action: Preservative Choice Makes Unilever’s TRESemme Keratin Products ‘Defective’

The presence of formaldehyde releaser DMDM hydantoin in TRESemme Keratin shampoos pose undisclosed risks of hair loss and/or scalp irritation, as shown by hundreds of consumer complaints online, plaintiffs allege in proposed class actions filed in Illinois and New Jersey federal courts.

Brazilian Blowout Manufacturer Required To Label, Warn Users

Brazilian Blowout parent company GIB LLC has settled a class action suit in California that directs the firm to pay more than $4 million to class members and properly label products with all ingredients and warnings about potential health risks.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel